Orthopedic Implants Market to Grow at a CAGR of 5.4% During the Forecast Period; Growing Demand for Effective Orthopedic Diagnosis Options Propels Market Expansion

The global orthopedic implants market size was valued at USD 47.38 billion in 2024. The market is anticipated to grow from USD 49.73 billion in 2025 to USD 71.74 billion by 2032, exhibiting a CAGR of 5.4% during the forecast period.

Fortune Business Insights™ presents this information in its report titled, “Orthopedic Implants Market Size, Share & Industry Analysis, By Product (Joint Reconstruction [Knee, Hip, and Extremities], Spinal Implants [Spinal Fusion Devices, and Spinal Non-fusion Devices], Trauma Implants, and Others), By Material (Metal Alloys, Polymers, Ceramics, Hybrid), By Procedure (Hip Arthroplasty, Knee Arthroplasty, Spinal Procedure, and Others), By End-user (Hospitals & Ambulatory Surgery Centers, and Orthopedic Clinics & Others), and Regional Forecast, 2025-2032”. 

Orthopedic implants aid in replacing and supporting joints or bones with a focus on reducing pain and improving functionality. The increasing burden of orthopedic disorders, with demand for effective treatment options, is boosting the overall market growth. Additionally, various market players, including DePuy Synthes (Johnson & Johnson Services Inc.), Zimmer Biomet, Smith & Nephew, and others, are focusing on introducing new developments and launching innovative technologies to strengthen their market position.

Smith+Nephew Acquired Engage Surgical to Enhance its Knee Implant Products

January 2022- Smith+Nephew acquired a U.S.-based company, Engage Surgical. The firm had introduced the Partial Knee System cementless knee implant, and with this acquisition the the firm aimed to strengthen its knee implant products.

Growing Geriatric Population and Orthopedic Disorders to Augment Market Growth

The increasing geriatric population is fuelling the issue of orthopedic ailments, including arthritis, bone abnormalities, fractures, and others. This, in turn, is driving the orthopedic implants market growth. Additionally, different favourable reimbursement situations for orthopedic procedures also boost the market expansion. There is a growing investment by market players in developing novel products, which could drive the market development. Increasing competition and the demand for bone implantation have triggered market players to invest in R&D of new implants and focus on customization.

Conversely, the substantial cost of orthopedic implants is hindering market growth.

Top Players Emphasize New Product Launches to Strengthen Their Market Presence

The global market consists of numerous players with strong bone implant product portfolios and growing investments in research and development for innovative new, technologically refined implants. This would help the players sustain growing competition.

Notable Industry Development

• November 2024: Zimmer Biomet acknowledged the U.S. Food and Drug Administration (FDA) Premarket Approval Application (PMA) Supplement approval. This was for Oxford cementless partial knee implant.

List of the Companies Profiled in the Report

• Zimmer Biomet (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Smith+Nephew (U.K.)
• Stryker (U.S.)
• Agilent Technologies, Inc. (U.S.)
• CONMED Corporation (U.S.)
• Medtronic (Ireland)
• DJO LLC. (U.S.)
• Exactech, Inc. (U.S.)
• Corin Group (U.K.)
• Conformis (U.S.)
• United Orthopedic Corporation (U.S.)
• Medacta International (Switzerland)
• Globus Medical (U.S.)
• B. Braun SE (Germany)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/orthopedic-implants-market-101659

Further Report Findings

• North America held the highest orthopedic implants market share, attributed to the rising burden of orthopedic disorders, including bone-related disorders, which could lead to bone fracture cases.
• Market growth in Europe is driven by an increase in the number of patients with arthritis, musculoskeletal, and other bone-related disorders across the region.
• Market expansion in South America is propelled by the increasing in patients receiving orthopedic treatments owing to advancements in bone scale treatments.
• In terms of end-user, the hospitals & outpatient surgery segment led the market in 2024, due to effective reimbursement policies offered by large hospitals.
• Based on product, the joint reconstruction segment led the market due to a growing number of knee and hip procedures occurring globally.

Table of Segmentation